Market Tracker

03/24 12:02pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

10.53
Delayed Data
As of 11:46am ET
 +0.17 / +1.64%
Today’s Change
8.78
Today|||52-Week Range
16.54
+0.67%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close10.36
Today’s open10.40
Day’s range10.39 - 10.65
Volume16,246
Average volume (3 months)67,455
Market cap$176.7M
Dividend yield--
Data as of 11:46am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratio--
Price/Sales1,329.82
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...-5.02-51.02%
MDGLMadrigal Pharmaceuti...-0.14-0.92%
FBIOFortress Biotech Inc+0.09+2.60%
ABUSArbutus Biopharma Co...+0.05+1.59%
Data as of 12:00pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts